Singapore Eye Research Institute

This early-stage trial tests a lab-grown corneal graft made from human cells to treat mild to moderate corneal disease. About 30 adults with conditions like Fuchs' dystrophy or post-surgery damage will receive the graft. The goal is to see if it is safe and can improve vision wit…

This study tests whether an artificial intelligence (AI) system can accurately screen for glaucoma, a leading cause of blindness, in people with diabetes. About 1040 participants will be randomly assigned to either the AI-assisted screening or the current standard method. The goa…

This study compares two laser platforms (VISUMAX 500 and VISUMAX 800) used in SMILE surgery to correct nearsightedness. About 100 participants will receive the procedure to see if the newer machine provides the same or better vision results. The goal is to improve surgical outcom…

This study tests whether a treatment called Quantum Molecular Resonance (QMR) can reduce eye pain and help regrow damaged nerves in the cornea. About 30 adults with neuropathic corneal pain will receive eight QMR sessions. Researchers will measure pain levels, nerve health, and q…

This study tests whether eye drops made from cord plasma can relieve pain caused by damaged nerves in the eye. Researchers will enroll 20 adults with persistent eye pain and nerve abnormalities. The drops aim to reduce pain and inflammation, and participants will report their pai…